Early continuous renal replacement therapy in septic acute kidney injury could be defined by its initiation within 24 hours of vasopressor infusion

J Crit Care. 2017 Jun:39:108-114. doi: 10.1016/j.jcrc.2016.12.014. Epub 2016 Dec 27.

Abstract

Purpose: The optimal timing for the initiation of early continuous renal replacement therapy (CRRT) is uncertain and requires a practically feasible definition with acceptable evidence.

Materials and methods: We investigated the clinical impacts of 3-time interval parameters on the morbidity and mortality of 177 patients with septic shock-induced acute kidney injury: (1) time from vasopressor initiation to CRRT initiation (Tvaso-CRRT), (2) time from intensive care unit (ICU) admission to CRRT initation (TICU-CRRT), and (3) time from endotracheal intubation to CRRT initiation (Tendo-CRRT).

Results: The proportion of the patients with Tvaso-CRRT less than 24 h (median, 14 h, interquartile range [IQR], 5-30 h) was significantly higher in the survival group than in the non-survival group (84.3% vs. 58.5%, p < 0.001). Tvaso-CRRT less than 24 h and Sequential Organ Failure Assessment score were independent factors associated with 28-day mortality and 90-day mortality. TICU-CRRT (median, 17 h, IQR, 5-72 h) and Tendo-CRRT (median, 13 h, IQR, 4-48 h) were significantly correlated with both the length of ICU stay (p < 0.001) and mechanical ventilation duration (p < 0.001), but not mortality.

Conclusions: Considering the possible therapeutic measurement by physician on the basis of the results in this study, early CRRT could be defined by a Tvaso-CRRT less than 24 h.

Keywords: Critical care; Mortality; Renal function; Renal replacement therapy.

MeSH terms

  • Acute Kidney Injury / etiology
  • Acute Kidney Injury / mortality
  • Acute Kidney Injury / therapy*
  • Aged
  • Female
  • Humans
  • Infusions, Intravenous
  • Intensive Care Units
  • Male
  • Middle Aged
  • Organ Dysfunction Scores
  • Renal Replacement Therapy / methods*
  • Renal Replacement Therapy / mortality
  • Retrospective Studies
  • Shock, Septic / complications
  • Shock, Septic / mortality
  • Time-to-Treatment
  • Vasoconstrictor Agents / administration & dosage*

Substances

  • Vasoconstrictor Agents